 |
PDBsum entry 1k5o
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Protein binding
|
PDB id
|
|
|
|
1k5o
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Mol Biol
314:839-849
(2001)
|
|
PubMed id:
|
|
|
|
|
| |
|
Solution NMR structure of the myosin phosphatase inhibitor protein CPI-17 shows phosphorylation-induced conformational changes responsible for activation.
|
|
S.Ohki,
M.Eto,
E.Kariya,
T.Hayano,
Y.Hayashi,
M.Yazawa,
D.Brautigan,
M.Kainosho.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Contractility of vascular smooth muscle depends on phosphorylation of myosin
light chains, and is modulated by hormonal control of myosin phosphatase
activity. Signaling pathways activate kinases such as PKC or Rho-dependent
kinases that phosphorylate the myosin phosphatase inhibitor protein called
CPI-17. Phosphorylation of CPI-17 at Thr38 enhances its inhibitory potency
1000-fold, creating a molecular on/off switch for regulating contraction. We
report the solution NMR structure of the CPI-17 inhibitory domain (residues
35-120), which retains the signature biological properties of the full-length
protein. The final ensemble of 20 sets of NMR coordinates overlaid onto their
mean structure with r.m.s.d. values of 0.84(+/-0.22) A for the backbone atoms.
The protein forms a novel four-helix, V-shaped bundle comprised of a central
anti-parallel helix pair (B/C helices) flanked by two large spiral loops formed
by the N and C termini that are held together by another anti-parallel helix
pair (A/D helices) stabilized by intercalated aromatic and aliphatic
side-chains. Chemical shift perturbations indicated that phosphorylation of
Thr38 induces a conformational change involving displacement of helix A, without
significant movement of the other three helices. This conformational change
seems to flex one arm of the molecule, thereby exposing new surfaces of the
helix A and the nearby phosphorylation loop to form specific interactions with
the catalytic site of the phosphatase. This phosphorylation-dependent
conformational change offers new structural insights toward understanding the
specificity of CPI-17 for myosin phosphatase and its function as a molecular
switch.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Figure 3. The solution NMR structure of CPI-17-[35-120].
(a) Stereo view of the backbone (N, C^a, and C') of 20
superimposed structures. The phosphorylation site T38 is colored
orange within the N-terminal region colored yellow. Helices are
colored royal-blue. (b) Ribbon representation of an
energy-minimized average structure of CPI-17-[35-120]. Helix
regions are royal-blue and yellow. The side-chain of Thr38 is
depicted by a ball-and-stick model. The first and last residues
of each helix are labeled with the residue number and the
helices are labeled with upper-case letters. The N-term. and
C-term. labels show the positions of the amino and carboxyl ends
of the protein, respectively.
|
 |
Figure 6.
Figure 6. Front and back views of the molecular surface of
CPI-17-[35-120] colored according to electrostatic potential.
Negative and positive charged areas are colored in red and blue,
respectively. Small ribbon models viewed from the identical
perspective are drawn at the side of both molecules for
orientation. Several amino acid residues are labeled.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2001,
314,
839-849)
copyright 2001.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
B.Dancheck,
A.C.Nairn,
and
W.Peti
(2008).
Detailed structural characterization of unbound protein phosphatase 1 inhibitors.
|
| |
Biochemistry,
47,
12346-12356.
|
 |
|
|
|
|
 |
M.Eto,
T.Kitazawa,
F.Matsuzawa,
S.Aikawa,
J.A.Kirkbride,
N.Isozumi,
Y.Nishimura,
D.L.Brautigan,
and
S.Y.Ohki
(2007).
Phosphorylation-induced conformational switching of CPI-17 produces a potent myosin phosphatase inhibitor.
|
| |
Structure,
15,
1591-1602.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
D.J.Hartshorne,
M.Ito,
and
F.Erdödi
(2004).
Role of protein phosphatase type 1 in contractile functions: myosin phosphatase.
|
| |
J Biol Chem,
279,
37211-37214.
|
 |
|
|
|
|
 |
M.Eto,
T.Kitazawa,
and
D.L.Brautigan
(2004).
Phosphoprotein inhibitor CPI-17 specificity depends on allosteric regulation of protein phosphatase-1 by regulatory subunits.
|
| |
Proc Natl Acad Sci U S A,
101,
8888-8893.
|
 |
|
|
|
|
 |
M.Eto,
R.Bock,
D.L.Brautigan,
and
D.J.Linden
(2002).
Cerebellar long-term synaptic depression requires PKC-mediated activation of CPI-17, a myosin/moesin phosphatase inhibitor.
|
| |
Neuron,
36,
1145-1158.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |